EVALUATION OF PURIFIED POLOXAMER 188 IN VASO-OCCLUSIVE CRISIS OF SICKLE CELL DISEASE (EPIC): A PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL OF MST-188 (PURIFIED POLOXAMER 188) INJECTION IN SUBJECTS WITH SICKLE CELL DISEASE EXPERIENCING VASO-OCCLUSIVE CRISIS
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this research study is to learn if MST-188 can decrease the amount of time patients with sickle cell disease experience a VOC.
Description
The purpose of this study is to learn if MST-188 can decrease the amount of time patients with sickle cell disease experience a Vaso-Occlusive Crisis (VOC).
Details
| Condition | sickle cell disease |
|---|---|
| Age | 4years - 65years |
| Clinical Study Identifier | TX5082 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.